Contact this trialFirst, we need to learn more about you.
Extended Ibrutinib Treatment for Non-Hodgkin's Lymphoma
Recruiting3 awardsPhase 4
Tyler, Texas
This trial provides continued access to ibrutinib for those who have completed parent ibrutinib studies and are still benefitting, but have no access to commercial ibrutinib.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.